GoodRx (NASDAQ:GDRX) is facing lawsuits from several independent pharmacies who are accusing the company of working with pharmacy benefit managers to fix reimbursement fees.
The matter is relevant to the pharmacies as GoodRx markets a prescription drug discount card that